<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03475147</url>
  </required_header>
  <id_info>
    <org_study_id>201610703</org_study_id>
    <nct_id>NCT03475147</nct_id>
  </id_info>
  <brief_title>Smartphone Flicker Fusion Test for Patients With Optic Disorders.</brief_title>
  <official_title>Validation of a Smartphone-Based Flicker Fusion Test</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Randy Kardon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this project is to validate a quick, easy-to-use and administer smartphone
      flicker fusion test. The app (called eyeFusion) can potentially be used to easily and quickly
      collect critical flicker fusion measurements on patients admitted with optic disorders as
      part of the clinical care process.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The smartphone app developed is a flicker fusion that presents the subject with a series of
      stimuli consisting of a flickering pattern of bars above or below a static rectangle. For
      each stimulus presentation, the user has to tap the region that is flickering. The duration
      of the app is less than 2 minutes.

      This study will assess the validity of the test construct in measuring flicker fusion
      thresholds, and serve as a foundation for further iterative designs of the app and future
      validation and characterization studies.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 27, 2017</start_date>
  <completion_date type="Anticipated">January 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assess Validity of the test construct measuring flicker fusion thresholds.</measure>
    <time_frame>1/1/2020</time_frame>
    <description>The smartphone app developed is a flicker fusion that presents the subject with a series of stimuli consisting of a flickering pattern of bars above or below a static rectangle. The study will assess the validity of the test construct in measuring flicker fusion thresholds, and serve as a foundation for further iterative designs of the app and future validation and characterization studies.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Scotoma</condition>
  <arm_group>
    <arm_group_label>eyeFusion Control Subjects</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Healthy normal controls with no known eye disorders age 18-80.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>eyeFusion Patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Scotoma subjects aged 18-80.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>eyeFusion</intervention_name>
    <description>Smartphone app based flicker fusion test.</description>
    <arm_group_label>eyeFusion Control Subjects</arm_group_label>
    <arm_group_label>eyeFusion Patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Control

          -  Age matched 18-80 years of age.

          -  Healthy normal controls with no known eye disorders.

        Exclusion Criteria:

          -  Scotoma or any other ocular disorder

        Inclusion Criteria - Patients

          -  Age 18-80

          -  Clinically associated scotoma

        Exclusion Criteria - Patients

        -Any other ocular disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Randy Kardon, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julie K Nellis, BSN</last_name>
    <phone>319-356-2780</phone>
    <email>julie-nellis@uiowa.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jan Full, BSN</last_name>
    <phone>319-356-8299</phone>
    <email>jan-full@uiowa.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52240</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Randy Kardon, MD, PhD</last_name>
      <phone>319-356-2260</phone>
      <email>randy-kardon@uiowa.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>March 16, 2018</study_first_submitted>
  <study_first_submitted_qc>March 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2018</study_first_posted>
  <last_update_submitted>January 16, 2020</last_update_submitted>
  <last_update_submitted_qc>January 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Randy Kardon</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Scotoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

